
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
tsg 101 CRISPR/Cas9 KO Plasmid (m) | sc-423524 | 20 µg | $397.00 | |||
tsg 101 HDR Plasmid (m) | sc-423524-HDR | 20 µg | $445.00 |
Tsg101 (tsg 101) encodes a core component of the ESCRT-I complex that recognizes ubiquitinated membrane proteins and coordinates endosomal sorting, multivesicular body biogenesis, and lysosomal degradation. Through ESCRT-dependent membrane remodeling, TSG101 also contributes to cytokinetic abscission and is frequently studied in the context of extracellular vesicle/exosome biogenesis and budding of enveloped viruses. By controlling receptor turnover and membrane protein homeostasis, TSG101 influences signaling outputs from pathways such as EGFR and other growth factor receptors. Dysregulation of endolysosomal trafficking and ESCRT function is linked to proliferative defects, genomic instability, and neurodegenerative and cancer-associated phenotypes, making mouse Tsg101 a useful node for mechanistic studies of membrane dynamics.
tsg 101 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Tsg101 gene in mouse cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the Tsg101 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, tsg 101 HDR Plasmid (m) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined Tsg101 target site.
When co-transfected with tsg 101 CRISPR/Cas9 KO Plasmid (m):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the Tsg101 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.